{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:00:36Z","timestamp":1758124836225},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,5,22]],"date-time":"2009-05-22T00:00:00Z","timestamp":1242950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s11892-009-0033-6","type":"journal-article","created":{"date-parts":[[2009,5,20]],"date-time":"2009-05-20T20:25:19Z","timestamp":1242851119000},"page":"200-207","source":"Crossref","is-referenced-by-count":19,"title":["Lessons learned from studying families genetically predisposed to type 2 diabetes mellitus"],"prefix":"10.1007","volume":"9","author":[{"given":"Kenneth","family":"Cusi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,22]]},"reference":[{"key":"33_CR1","volume-title":"Diabetes and Exercise","author":"K. Cusi","year":"2009","unstructured":"Cusi K: The epidemic of type 2 diabetes mellitus: its links to obesity, insulin resistance and lipotoxicity. In Diabetes and Exercise. Edited by Regensteiner JG, Reusch JE, Stewart K, Veves A. Totowa, NJ: Humana Press; 2009 (in press)."},{"key":"33_CR2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00000441-200604000-00002","volume":"331","author":"Wyatt","year":"2006","unstructured":"Wyatt, Wyatt SB, Winters KP, Dubbert PM: Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 2006, 331:166\u2013174.","journal-title":"Am J Med Sci"},{"key":"33_CR3","first-page":"1115","volume-title":"Handbook of Physiology. The Endocrine Pancreas and Regulation of Metabolism","author":"K. Cusi","year":"2001","unstructured":"Cusi K, DeFronzo R: Non-insulin dependent diabetes mellitus. In Handbook of Physiology. The Endocrine Pancreas and Regulation of Metabolism. Edited by Jefferson LS, Cherrington AD. Oxford, UK: Oxford University Press, 2001:1115\u20131168."},{"key":"33_CR4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/MCO.0b013e3282ab9ea6","volume":"10","author":"A. Vaag","year":"2007","unstructured":"Vaag A, Poulsen P: Twins in metabolic and diabetes research: what do they tell us? Curr Opin Clin Nutr Metab Care 2007, 10:591\u2013596.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"33_CR5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.7326\/0003-4819-113-12-909","volume":"113","author":"J. Warram","year":"1990","unstructured":"Warram J, Krolewski A, Kahn C: Slow glucose removal rate and hyperinsulinemia precede the development of type 2 diabetes in offspring of diabetic parents. Ann Intern Med 1990, 113:909\u2013915.","journal-title":"Ann Intern Med"},{"key":"33_CR6","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2337\/db07-0140","volume":"56","author":"T.A. Buchanan","year":"2007","unstructured":"Buchanan TA: (How) can we prevent type 2 diabetes? Diabetes 2007, 56:1502\u20131507.","journal-title":"Diabetes"},{"key":"33_CR7","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2337\/diab.41.12.1575","volume":"41","author":"G. Gulli","year":"1992","unstructured":"Gulli G, Ferrannini E, Stern M, et al.: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992, 41:1575\u20131586.","journal-title":"Diabetes"},{"key":"33_CR8","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.2337\/diabetes.50.11.2572","volume":"50","author":"W. Pratipanawatr","year":"2001","unstructured":"Pratipanawatr W, Pratipanawatr T, Cusi K, et al.: Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation. Diabetes 2001, 50:2572\u20132578.","journal-title":"Diabetes"},{"key":"33_CR9","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/diabetes.52.10.2461","volume":"52","author":"S. Kashyap","year":"2003","unstructured":"Kashyap S, Belfort R, Gastaldelli A, et al.: A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003, 52:2461\u20132474.","journal-title":"Diabetes"},{"key":"33_CR10","doi-asserted-by":"crossref","first-page":"E537","DOI":"10.1152\/ajpendo.00541.2003","volume":"287","author":"S.R. Kashyap","year":"2004","unstructured":"Kashyap SR, Belfort R, Berria R, et al.: Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes. Am J Physiol Endocrin Metab 2004, 287:E537\u2013E546.","journal-title":"Am J Physiol Endocrin Metab"},{"issue":"Suppl1","key":"33_CR11","first-page":"A674","volume":"56","author":"M. Mathew","year":"2007","unstructured":"Mathew M, Tay C, Belfort R, et al.: A 48-hour elevation in plasma FFA, but not hyperglycemia, impairs insulin secretion in lean Mexican-American subjects genetically predisposed to T2DM. Diabetes 2007, 56(Suppl 1):A674.","journal-title":"Diabetes"},{"key":"33_CR12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa031314","volume":"350","author":"K.F. Petersen","year":"2004","unstructured":"Petersen KF, Dufour S, Befroy D, et al.: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004, 350:664\u2013671.","journal-title":"N Engl J Med"},{"key":"33_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diab.46.1.3","volume":"46","author":"G. Boden","year":"1997","unstructured":"Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997, 46:3\u201310.","journal-title":"Diabetes"},{"key":"33_CR14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/diabetes.49.5.677","volume":"49","author":"D. Kelley","year":"2000","unstructured":"Kelley D, Mandarino L: Fuel selection in human skeletal muscle in insulin resistance. A reexamination. Diabetes 2000, 49:677\u2013683.","journal-title":"Diabetes"},{"key":"33_CR15","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2337\/db06-S002","volume":"55","author":"K. Morino","year":"2006","unstructured":"Morino K, Petersen K, Shulman G: Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006, 55:S9\u2013S15.","journal-title":"Diabetes"},{"key":"33_CR16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1210\/jc.2003-031243","volume":"89","author":"H. Storgaard","year":"2004","unstructured":"Storgaard H, Jensen C, Bjornholm M, et al.: Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. J Clin Endocrinol Metab 2004, 89:1301\u20131311.","journal-title":"J Clin Endocrinol Metab"},{"key":"33_CR17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/diabetes.54.6.1640","volume":"54","author":"R. Belfort","year":"2005","unstructured":"Belfort R, Mandarino L, Kashyap S, et al.: Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 2005, 54:1640\u20131648.","journal-title":"Diabetes"},{"key":"33_CR18","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2337\/diabetes.50.10.2337","volume":"50","author":"A. Virkamaki","year":"2001","unstructured":"Virkamaki A, Korsheninnikova E, Seppala-Lindroos A, et al.: Intramyocellular lipid Is associated with resistance to in vivo Insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 2001, 50:2337\u20132343.","journal-title":"Diabetes"},{"key":"33_CR19","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1210\/jc.2002-021674","volume":"88","author":"C. Thamer","year":"2003","unstructured":"Thamer C, Machann J, Bachmann O, et al.: Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 2003, 88:1785\u20131791.","journal-title":"J Clin Endocrinol Metab"},{"key":"33_CR20","first-page":"72","volume-title":"The American Association for the Study of Liver Disease Postgraduate Course","author":"K. Cusi","year":"2008","unstructured":"Cusi K: Evolving concepts in lipotoxicity. In The American Association for the Study of Liver Disease Postgraduate Course. Alexandria, VA: American Association for the Study of Liver Disease; 2008:72\u201384."},{"key":"33_CR21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MOL.0b013e328321b3a8","volume":"20","author":"J. Szendroedi","year":"2009","unstructured":"Szendroedi J, Roden M: Ectopic lipids and organ function. Curr Opin Lipidol 2009, 20:50\u201356.","journal-title":"Curr Opin Lipidol"},{"key":"33_CR22","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db08-0038","volume":"57","author":"S.M. Reyna","year":"2008","unstructured":"Reyna SM, Ghosh S, Tantiwong P, et al.: Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 2008, 57:2595\u20132602.","journal-title":"Diabetes"},{"key":"33_CR23","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1073\/pnas.1032913100","volume":"100","author":"M.E. Patti","year":"2003","unstructured":"Patti ME, Butte AJ, Crunkhorn S, et al.: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003, 100:8466\u20138471.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"33_CR24","doi-asserted-by":"crossref","first-page":"E607","DOI":"10.1152\/ajpendo.00729.2007","volume":"294","author":"E. Filippis De","year":"2008","unstructured":"De Filippis E, Alvarez G, Berria R, et al.: Insulin-resistant muscle is exercise resistant: evidence for reduced response of nuclear-encoded mitochondrial genes to exercise. Am J Physiol Endocrinol Metab 2008, 294:E607\u2013E614.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"33_CR25","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.1074\/jbc.M408985200","volume":"280","author":"D.K. Richardson","year":"2005","unstructured":"Richardson DK, Kashyap S, Bajaj M, et al.: Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J Biol Chem 2005, 280:10290\u201310297.","journal-title":"J Biol Chem"},{"key":"33_CR26","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2337\/db06-0783","volume":"56","author":"D.E. Befroy","year":"2007","unstructured":"Befroy DE, Petersen KF, Dufour S, et al.: Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 2007, 56:1376\u20131381.","journal-title":"Diabetes"},{"key":"33_CR27","doi-asserted-by":"crossref","first-page":"E1775","DOI":"10.1152\/ajpendo.00624.2006","volume":"292","author":"K. Cusi","year":"2007","unstructured":"Cusi K, Kashyap S, Belfort R, et al.: Effects on insulin secretion and action of short-term reduction of plasma free fatty acids with acipimox in non-diabetic subjects genetically predisposed to type 2 diabetes. Am J Physiol Endocrinol Metab 2007, 292:E1775\u2013E1781.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"33_CR28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MED.0b013e3283293015","volume":"16","author":"K. Cusi","year":"2009","unstructured":"Cusi K: Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2009, 16:141\u2013149.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"33_CR29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1559-4572.2008.00013.x","volume":"3","author":"S. Kashyap","year":"2008","unstructured":"Kashyap S, Belfort R, Cersosimo E, et al.: Chronic low-dose lipid infusion in healthy patients induces markers of endothelial activation independent of its metabolic effects. J Cardiometab Syndr 2008, 3:141\u2013146.","journal-title":"J Cardiometab Syndr"},{"key":"33_CR30","first-page":"315","volume":"119","author":"R. Semple","year":"2009","unstructured":"Semple R, Sleigh A, Murgatroyd P, et al.: Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 2009, 119:315\u2013322.","journal-title":"J Clin Invest"},{"issue":"Suppl1","key":"33_CR31","first-page":"A66","volume":"55","author":"C. Tay","year":"2006","unstructured":"Tay C, Belfort R, Mathew M, Cusi K: A 2-day lipid or combined lipid-glucose infusion reproduce in healthy subjects the metabolic abnormalities seen in the metabolic syndrome. Diabetes 2006, 55(Suppl 1):A66.","journal-title":"Diabetes"},{"key":"33_CR32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jc.2007-1670","volume":"93","author":"P. Brassard","year":"2008","unstructured":"Brassard P, Frisch F, Lavoie F, et al.: Impaired plasma nonesterified fatty acid tolerance is an early defect in the natural history of type 2 diabetes. J Clin Endocrinol Metab 2008, 93:837\u2013844.","journal-title":"J Clin Endocrinol Metab"},{"key":"33_CR33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00125-004-1359-x","volume":"47","author":"A. Civitarese","year":"2004","unstructured":"Civitarese A, Jenkinson C, Richardson D, et al.: Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of type 2 diabetes. Diabetologia 2004, 47:816\u2013820.","journal-title":"Diabetologia"},{"key":"33_CR34","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s00125-006-0305-5","volume":"49","author":"C. Nolan","year":"2006","unstructured":"Nolan C, Leahy J, Delghingaro-Augusto V, et al.: Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling. Diabetologia 2006, 49:2120\u20132130.","journal-title":"Diabetologia"},{"issue":"Suppl1","key":"33_CR35","first-page":"A389","volume":"56","author":"M. Mathew","year":"2008","unstructured":"Mathew M, Darland C, Kumar P, et al.: Effect of obesity on insulin secretion in response to a 48-hour physiological increase in plasma FFA in Mexican-American subjects genetically predisposed to type 2 diabetes. Diabetes 2008, 56(Suppl 1):A389.","journal-title":"Diabetes"},{"key":"33_CR36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","volume":"47","author":"A. Gastaldelli","year":"2004","unstructured":"Gastaldelli A, Ferrannini E, Miyazaki Y, et al.: Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 2004, 47:31\u201339.","journal-title":"Diabetologia"},{"issue":"Suppl1","key":"33_CR37","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.2337\/diabetes.50.2007.S118","volume":"50","author":"R. Unger","year":"2001","unstructured":"Unger R, Zhou Y: Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001, 50(Suppl 1):S118\u2013S121.","journal-title":"Diabetes"},{"issue":"Suppl2","key":"33_CR38","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/db06-S003","volume":"55","author":"C.J. Nolan","year":"2006","unstructured":"Nolan CJ, Madiraju MS, Delghingaro-Augusto V, et al.: Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 2006, 55(Suppl 2):S16\u2013S23.","journal-title":"Diabetes"},{"key":"33_CR39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1463-1326.2007.00718.x","volume":"10","author":"K. Maedler","year":"2008","unstructured":"Maedler K: Beta cells in type 2 diabetes-a crucial contribution to pathogenesis. Diabetes Obesity Metabolism 2008, 10:408\u2013420.","journal-title":"Diabetes Obesity Metabolism"},{"key":"33_CR40","doi-asserted-by":"crossref","unstructured":"Delghingaro-Augusto V, Nolan C, Gupta D, et al.: Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass. Diabeteologia 2009 Mar 18 (Epub ahead of print).","DOI":"10.1007\/s00125-009-1317-8"},{"key":"33_CR41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0026-0495(00)80007-4","volume":"49","author":"C.M. Amery","year":"2000","unstructured":"Amery CM, Round RA, Smith JM, Nattrass M: Elevation of plasma fatty acids by ten-hour intralipid infusion has no effect on basal or glucose-stimulated insulin secretion in normal man. Metabolism 2000, 49:450\u2013454.","journal-title":"Metabolism"},{"key":"33_CR42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1749-6632.2002.tb04313.x","volume":"967","author":"B. Balent","year":"2002","unstructured":"Balent B, Goswami G, Goodloe G, et al.: Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Ann NY Acad Sci 2002, 967:535\u2013543.","journal-title":"Ann NY Acad Sci"},{"key":"33_CR43","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0026-0495(03)00102-1","volume":"52","author":"H. Storgaard","year":"2003","unstructured":"Storgaard H, Jensen C, Vaag A, et al.: Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes. Metabolism 2003, 52:885\u2013894.","journal-title":"Metabolism"},{"key":"33_CR44","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/BF00401761","volume":"38","author":"G. Paolisso","year":"1995","unstructured":"Paolisso G, Gambardella A, Amato L, et al.: Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 1995, 38:1295\u20131299.","journal-title":"Diabetologia"},{"key":"33_CR45","doi-asserted-by":"crossref","first-page":"E1055","DOI":"10.1152\/ajpendo.1999.276.6.E1055","volume":"276","author":"A. Carpentier","year":"1999","unstructured":"Carpentier A, Mittelman SD, Bergman RN, et al.: Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol Endocrinol Metab 1999, 276:E1055\u2013E1066.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"33_CR46","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI118160","volume":"96","author":"G. Boden","year":"1995","unstructured":"Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 1995, 96:1261\u20131268.","journal-title":"J Clin Invest"},{"key":"33_CR47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1172\/JCI3883","volume":"103","author":"C. Magnan","year":"1999","unstructured":"Magnan C, Collins S, Berthault MF, et al.: Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose. J Clin Invest 1999, 103:413\u2013419.","journal-title":"J Clin Invest"},{"key":"33_CR48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/diabetes.49.3.399","volume":"49","author":"A. Carpentier","year":"2000","unstructured":"Carpentier A, Mittelman SD, Bergman RN, et al.: Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 2000, 49:399\u2013408.","journal-title":"Diabetes"},{"issue":"Suppl1","key":"33_CR49","first-page":"A153","volume":"57","author":"M. Mathew","year":"2008","unstructured":"Mathew M, Kumar P, Ali R, et al.: Insulin secretion in patients with impaired glucose tolerance (IGT) is readily susceptible to FFA-induced lipotoxicity. Diabetes 2008, 57(Suppl 1):A153.","journal-title":"Diabetes"},{"key":"33_CR50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","volume":"105","author":"K. Cusi","year":"2000","unstructured":"Cusi K, Maezono K, Osman A, et al.: Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000, 105:311\u2013320.","journal-title":"J Clin Invest"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-009-0033-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-009-0033-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-009-0033-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:56:21Z","timestamp":1559418981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-009-0033-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,22]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1007\/s11892-009-0033-6","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,22]]}}}